Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
or
Menu

Enzon Pharma Inc (ENZN) OTHER OTC

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (BATS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ fieldTitles[key] ]] [[ value ]] [[ value ]]
3-Month Performance
View Chart

Fundamentals

See More
  • Market Capitalization, $K 12,824
  • Shares Outstanding, K 44,220
  • Annual Sales, $ 17,460 K
  • Annual Income, $ 21,640 K
  • 36-Month Beta 1.06
  • Price/Sales 1.20
  • Price/Cash Flow N/A
  • Price/Book 0.61
  • Price/Earnings ttm 1.03
  • Earnings Per Share ttm 0.33
  • Most Recent Earnings N/A on N/A
  • Next Earnings Date 03/20/17
  • Annual Dividend & Yield 0.15 (50.05%)
  • Most Recent Dividend 0.30 on 12/13/16
  • Sectors:

Price Performance

See More
Period Period Low Period High Performance
1-Month
0.2805 +3.39%
on 03/21/17
0.3500 -17.14%
on 02/23/17
-0.0500 (-14.71%)
since 02/22/17
3-Month
0.2805 +3.39%
on 03/21/17
0.3776 -23.20%
on 01/11/17
-0.0600 (-17.14%)
since 12/22/16
52-Week
0.2805 +3.39%
on 03/21/17
0.5600 -48.21%
on 04/15/16
-0.1500 (-34.09%)
since 03/22/16

Most Recent Stories

More News
Enzon Pharmaceuticals Partnering Deals and Alliances 2010 to 2017

SummaryThis report provides all the information you require to better understand Enzon Pharmaceuticals and its partnering interests and activities since 2010.

ENZN : 0.2900 (-3.24%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 96% Sell with a Strongest short term outlook on maintaining the current direction.

Longer term, the trend strength is Maximum. Long term indicators fully support a continuation of the trend.

See More

Support & Resistance

2nd Resistance Point 0.2953
1st Resistance Point 0.2927
Last Price 0.2900
1st Support Level 0.2847
2nd Support Level 0.2793

See More

Add Data Columns to this Table
Learn about our Custom Views
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.